MAPT and Alzheimer disease: This interpretation is supported by the study by Van Egroo and colleagues, which in 2023 published a report on cognitively unimpaired elderlies in which they assessed LC integrity through 7 T MRI scan and explored its association with plasmatic hyperphosphorylated tau (pTau) levels, considered a proxy for cortical AD–related tau pathology [48••].